Atrás
Rango del Día
$3.03
$3.28
Rango de 52 Semanas
$3.03
$11.85
Volumen
1,130,277
Promedio 50D / 200D
$4.53
/
$6.85
Cierre Anterior
$3.33
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.2 | 0.3 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -47.4 | 3.8 |
| Rev Growth 5Y % | 64.7 | 10.0 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
Hold
$8.60
+174.8%
Low: $5.00
High: $10.00
P/E Futuro
37.0
EPS Futuro
$0.09
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
640 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$2.08
$1.62 – $2.49
|
1.7 B | 1 |
| FY2029 |
$1.17
$0.91 – $1.40
|
1.4 B | 1 |
| FY2028 |
$0.56
$0.15 – $0.97
|
1 B | 2 |
Puntos Clave
Revenue grew 64.66% annually over 5 years — strong growth
Negative free cash flow of -293.84M
PEG of 0.24 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 370.90%
Interest coverage of 0.44× — tight debt servicing
Crecimiento
Revenue Growth (5Y)
64.66%
Revenue (1Y)435.56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC6.72%
Net Margin-47.35%
Op. Margin14.22%
Seguridad
Debt / Equity
N/A
Current Ratio2.35
Interest Coverage0.44
Valoración
P/E Ratio
-4.21
P/B RatioN/A
EV/EBITDA30.36
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 435.56% | Revenue Growth (3Y) | 142.85% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 64.66% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 489.68M | Net Income (TTM) | -231.86M |
| ROE | N/A | ROA | -18.98% |
| Gross Margin | 62.16% | Operating Margin | 14.22% |
| Net Margin | -47.35% | Free Cash Flow (TTM) | -293.84M |
| ROIC | 6.72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.35 |
| Interest Coverage | 0.44 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.21 | P/B Ratio | N/A |
| P/S Ratio | 1.99 | PEG Ratio | 0.24 |
| EV/EBITDA | 30.36 | Dividend Yield | 0.00% |
| Market Cap | 975.31M | Enterprise Value | 2.11B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 489.68M | 91.43M | 83.03M | 36.77M | 66.62M |
| Net Income | -231.86M | -551.73M | -513.58M | -101.50M | -170.04M |
| EPS (Diluted) | -0.87 | -2.43 | -2.60 | -3.25 | -5.44 |
| Gross Profit | 304.37M | -69.42M | 18.93M | 36.77M | 66.62M |
| Operating Income | 69.64M | -354.86M | -346.44M | -235.46M | -137.54M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1.22B | 950.09M | 828.44M | 597.98M | 474.42M |
| Total Liabilities | 1.63B | 1.88B | 1.39B | 733.59M | 1.34B |
| Shareholders' Equity | -412.77M | -932.49M | -564.42M | -135.61M | -867.24M |
| Total Debt | 1.19B | 1.08B | 805.10M | 523.05M | 676.85M |
| Cash & Equivalents | 51.43M | 11.16M | 66.43M | 17.56M | 31.69M |
| Current Assets | 455.02M | 194.84M | 230.74M | 119.82M | 86.16M |
| Current Liabilities | 193.40M | 260.95M | 167.29M | 111.84M | 50.98M |